Medication administration errors leading to death are common with anticoagulants and antibiotics in particular, according to a new study that analysed incidents reported in England and Wales. The most common error category was omitted medicine, followed by a wrong dose or a wrong strength. In half of the reported incidents, the patient was aged over 75.
“Our findings show that more attention should be paid to the safe administration of medication especially when it comes to older people. It is important to make sure that the patient gets the right dose of medication at the right time and in the right way,” says Academy of Finland Postdoctoral Researcher Marja Härkänen, the lead author of the article, from the University of Eastern Finland.
The study was conducted in collaboration between the University of Eastern Finland, King’s College London, University College London and the NIHR Imperial Patient Safety Translational Research Centre, London. The findings were newly published in Research in Social and Administrative Pharmacy.
The data for the study was obtained from the National Reporting and Learning System for England and Wales, where medication administration errors were reported between 2007 and 2016. During this time period, health care professionals reported a total of 517,384 medication administration errors in the system. The researchers analysed incidents reported as resulting in death, 229 cases in total.
Incidents resulting in death were most often reported on hospital wards (66%) and in patients aged over 75 years. The drug groups most commonly associated with administration errors were cardiovascular drugs, drugs impacting on the nervous system and drugs for treating infections. The individual drugs most commonly associated with administration errors, on the other hand, were injectable anticoagulants, antibiotics and analgesics. Nearly one third of the medication administration errors were omissions, with a wrong dose or a wrong strength as the next most common error categories.
According to Professor Katri Vehviläinen-Julkunen from the University of Eastern Finland, medication administration errors are common. “Although all errors do not cause harm to the patient, it is important to work to prevent especially those that do. This requires sufficient human resources and competent staff, as well as technological and digital solutions that promote competence development among staff, and that ensure medication safety.”
“While incident report data are subject to under-reporting, under-reporting may be less likely for errors that result in death, and so this study also represents a useful approach to learning from reported medication incidents. It also highlights the importance of preventing the omission of doses, as these were commonly implicated in our data," commented Professor Bryony Dean Franklin from University College London and the NIHR Imperial Patient Safety Translational Research Centre.
“This study demonstrates the vulnerability of the elderly to missed medication errors and the need for vigilance in avoiding serious consequences for patient safety and quality of care,” Professor Anne Marie Rafferty from King’s College London concludes.
For further information, please contact:
Postdoctoral Researcher Marja Härkänen, University of Eastern Finland, marja.harkanen (a) uef.fi, tel. +358403552614
Marja Härkänen, Katri Vehviläinen-Julkunen, Trevor Murrells, Anne Marie Rafferty, Bryony Dean Franklin. Medication administration errors and mortality: incidents reported in England and Wales between 2007 ̶ 2016. Research in Social & Administrative Pharmacy (2018), doi: https://doi.org/10.1016/j.sapharm.2018.11.010
The National Institute for Health Research (NIHR) is the UK's largest funder of health and care research. The NIHR:
- Funds, supports and delivers high quality research that benefits the NHS, public health and social care
- Engages and involves patients, carers and the public in order to improve the reach, quality and impact of research
- Attracts, trains and supports the best researchers to tackle the complex health and care challenges of the future
- Invests in world-class infrastructure and a skilled delivery workforce to translate discoveries into improved treatments and services
- Partners with other public funders, charities and industry to maximise the value of research to patients and the economy
- The NIHR was established in 2006 to improve the health and wealth of the nation through research, and is funded by the Department of Health and Social Care. In addition to its national role, the NIHR commissions applied health research to benefit the poorest people in low- and middle-income countries, using Official Development Assistance funding.
This work uses data provided by patients and collected by the NHS as part of their care and support and would not have been possible without access to this data. The NIHR recognises and values the role of patient data, securely accessed and stored, both in underpinning and leading to improvements in research and care. www.nihr.ac.uk/patientdata